Merrill Lynch analyst Eddie Leung wrote to clients that
he expects "lower monetization on the pharmaceutical sector
and conservatively some extra impact on traffic and advertiser
growth." He lowered his 2009 revenue estimate by 17 percent
and his earnings-per-share estimate by 22 percent.
No comments:
Post a Comment